/C O R R E C T I O N -- Wormington & Bollinger/

In the news release, AbbVie, Inc.'s Zymaxid tm Implicated in Product Liability Lawsuit Due to Risk of Serious Injury and Death, issued 02-Jul-2024 by Wormington & Bollinger over PRWeb, the source of the release should be "Wormington & Bollinger" rather than "AbbVie, Inc." as incorrectly transmitted by PRWeb. Additionally, the headline has been updated to further clarify the sourcing. The complete, corrected release follows:

Wormington & Bollinger: AbbVie, Inc.'s Zymaxid tm Implicated in Product Liability Lawsuit Due to Risk of Serious Injury and Death

AbbVie faces lawsuit over Zymaxidtm.

MCKINNEY, Texas, July 2, 2024 /PRNewswire-PRWeb/ -- Wormington & Bollinger is actively reviewing product liability cases associated with antibiotic eyedrops causing Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

AbbVie, Inc. (NYSE: ABBV), a pharmaceutical company headquartered in Chicago, Illinois, is facing a product liability lawsuit, filed by plaintiff, Alicia Burton in Los Angeles, California. Burton alleges that she sustained catastrophic injuries stemming from the use of AbbVie's ophthalmic medication, Zymaxidtm (topical gatifloxacin).

In Alicia Burton v. Allergan, Inc. and AbbVie, Inc. Case No. 2:22-cv-05920 in the U.S. District Court for the Central District of California, the plaintiff alleges that she suffered from SJS and TEN in 2019 after using AbbVie's Zymaxidtm eye drops. This resulted in severe ocular injuries, disfiguring scarring and permanently disabling injuries.

SJS and TEN are severe life-threatening reactions to medications with mortality rates as high as 70%, often resulting in permanent blindness, skin detachment, and irreversible physical disfigurement from burns.

AbbVie's prescription medication, Zymaxidtm, is a quinolone antibiotic in eye drop form. While antibiotics taken orally and by IV have been long implicated as a common cause of SJS and TEN, cases caused by eye drop formulations of different antibiotics are on the rise.

AbbVie manufactures antibiotic eye drops marketed under the following trade names: Zymaxidtm, Zymartm, Ocufloxtm, Bleph-10tm, and Blephamidetm.

Consumers should seek medical attention immediately upon experiencing any of the symptoms listed above. Consumers experiencing SJS and TEN caused by antibiotic eyedrops or other prescription drugs are urged to contact Wormington & Bollinger for a free case evaluation.

About Wormington & Bollinger

Lennie F. Bollinger is an attorney headquartered in McKinney, Texas. Mr. Bollinger serves clients across the U.S. in cases involving personal injury, medical malpractice, pharmaceutical and drug-device litigation, truck wrecks, product liability, premises liability, and multi-district litigation.

Media Contact

Jeremy Friesen, Wormington & Bollinger, 1 888-967-6529, [email protected], https://www.wormingtonlegal.com/

SOURCE Wormington & Bollinger